Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119932) titled 'Combined Cryoablation, Lucan-Sartuzumab, and Immunotherapy for Advanced Cholangiocarcinoma (SPICE Trial): A Phase II Single-Arm Study' on March 5.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Lishui Central Hospital
Condition:
Local advanced/Metastatic intrahepatic cholangiocarcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-04-05
Target Sample Size: Experimental group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=309697
Published by HT Digital Content Services with permission fro...